SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001628280-24-012578
Filing Date
2024-03-21
Accepted
2024-03-21 17:08:31
Documents
97
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 10-K xfor-20231231.htm   iXBRL 10-K 2023203
2 EX-10.37 ex1037catalentamendement3.htm EX-10.37 16244
3 EX-23.1 ex-231x4x10xkpwcconsentxfy.htm EX-23.1 2405
4 EX-31.1 ex-311q42023.htm EX-31.1 10050
5 EX-31.2 ex-312q42023.htm EX-31.2 9959
6 EX-32.1 ex-321q42023.htm EX-32.1 5430
7 EX-97.1 ex971compensationrecoupmen.htm EX-97.1 43088
13 GRAPHIC xfor-20231231_g1.jpg GRAPHIC 47514
  Complete submission text file 0001628280-24-012578.txt   9912956

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT xfor-20231231.xsd EX-101.SCH 72190
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT xfor-20231231_cal.xml EX-101.CAL 77490
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT xfor-20231231_def.xml EX-101.DEF 355561
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT xfor-20231231_lab.xml EX-101.LAB 733039
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT xfor-20231231_pre.xml EX-101.PRE 587001
101 EXTRACTED XBRL INSTANCE DOCUMENT xfor-20231231_htm.xml XML 1333498
Mailing Address 61 NORTH BEACON STREET 4TH FLOOR BOSTON MA 02134
Business Address 61 NORTH BEACON STREET 4TH FLOOR BOSTON MA 02134 857-529-8300
X4 Pharmaceuticals, Inc (Filer) CIK: 0001501697 (see all company filings)

IRS No.: 273181608 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-38295 | Film No.: 24772234
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)